Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer

Estrogen receptor-positive, progesterone receptor-negative, and human epidermal growth factor receptor 2 (HER2)-negative (ER+PR-HER2-) breast cancer comprise a special type of breast cancer that constitutes ~10% of all breast cancer patients. ER+PR-HER2- tumor benefits less from endocrine therapy, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xi-Yu, Ma, Ding, Xu, Xiao-En, Jin, Xi, Yu, Ke-Da, Jiang, Yi-Zhou, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299689/
https://www.ncbi.nlm.nih.gov/pubmed/30613307
http://dx.doi.org/10.7150/thno.29164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299689/
https://www.ncbi.nlm.nih.gov/pubmed/30613307
http://dx.doi.org/10.7150/thno.29164

Ejemplares similares